<DOC>
	<DOC>NCT00141258</DOC>
	<brief_summary>To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures</brief_summary>
	<brief_title>Pregabalin Epilepsy Add-On Trial</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Have a diagnosis of epilepsy with partial seizures (as defined in the ILAE Classification of Seizures) and be currently taking 13 AEDs Have a minimum of 4 partial seizures occurring over at least 2 days during the 6week baseline with no 28day period free of partial seizures Have a treatable cause of seizures Are currently receiving treatment with CNSactive compounds (exception: single antidepressant, hypnotics, and standard AEDs), vigabatrin, Felbatol (felbamate), Neurontin (gabapentin)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>